The controversial project of an EU-wide clinical evaluation of medicinal products and medical devices (Health Technology Assessment, HTA) is coming to an end after years of wrangling. The agreement reached between Parliament and the Council in the summer has now been formally confirmed by the European Parliament. However, there will be no binding assessment of clinical benefit for all member states.
